Avoiding Drug Resistance in HIV Reverse Transcriptase
Open accessThe DOI matches its Crossref record; 305 of the 305 references it cites were found in a registry or an index.
Abstract
HIV reverse transcriptase (RT) is an enzyme that plays a major role in the replication cycle of HIV and has been a key target of anti-HIV drug development efforts. Because of the high genetic diversity of the virus, mutations in RT can impart resistance to various RT inhibitors. As the prevalence of drug resistance mutations is on the rise, it is necessary to design strategies that will lead to drugs less susceptible to resistance. Here we provide an in-depth review of HIV reverse transcriptase, current RT inhibitors, novel RT inhibitors, and mechanisms of drug resistance. We also present novel strategies that can be useful to overcome RT's ability to escape therapies through drug resistance. While resistance may not be completely avoidable, designing drugs based on the strategies and principles discussed in this review could decrease the prevalence of drug resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Resistance to them mainly arises from the high error rate of HIV reverse transcriptase (RT) during replication. The key resistance mechanisms involve either excision, where a mutated RT removes an incorporated NRTI, or discrimination, where mutations alter the dNTP-binding pocket to selectively block NRTI-triphosphate incorporation (4, 40).”
From Research progress on HIV-1 structural proteins and antiviral therapies (2026) · cites this paper as [40]
The cited source says what the claim attributes to it.
In the citing paper
“NNRTIs inhibit HIV-1 reverse transcriptase (RT) by binding to a specific, non-catalytic hydrophobic pocket known as the non-nucleoside inhibitor binding pocket (NNIBP). This binding site is located approximately 10 Å from the polymerase active site. The interaction induces conformational changes in RT that disrupt its enzymatic function, thereby inhibiting viral DNA synthesis (40, 45).”
From Research progress on HIV-1 structural proteins and antiviral therapies (2026) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
Ho, D. D., Neumann, A. U., Perelson, A. S., Chen, W., Leonard, J. M., & Markowitz, M. (1995) · Nature · doi:10.1038/373123a0 · Cited by 4,267
HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time
Perelson, A. S., Neumann, A. U., Markowitz, M., Leonard, J. M., & Ho, D. D. (1996) · Science · doi:10.1126/science.271.5255.1582 · Cited by 3,531
Viral dynamics in human immunodeficiency virus type 1 infection
Wei, X., Ghosh, S. K., Taylor, M. E., Johnson, V. A., Emini, E. A., Deutsch, P., Lifson, J. D., Bonhoeffer, S., Nowak, M. A., Hahn, B. H., et al. (1995) · Nature · doi:10.1038/373117a0 · Cited by 3,260
Computational protein–ligand docking and virtual drug screening with the AutoDock suite
Forli, S., Huey, R., Pique, M. E., Sanner, M. F., Goodsell, D. S., & Olson, A. J. (2016) · Nature Protocols · doi:10.1038/nprot.2016.051 · Cited by 2,811
Complete nucleotide sequence of the AIDS virus, HTLV-III
Ratner, L., Haseltine, W., Patarca, R., Livak, K. J., Starcich, B., Josephs, S. F., Doran, E. R., Rafalski, J. A., Whitehorn, E. A., Baumeister, K., et al. (1985) · Nature · doi:10.1038/313277a0 · Cited by 2,245
Computational Methods in Drug Discovery
Sliwoski, G., Kothiwale, S., Meiler, J., & Lowe, E. W. (2014) · Pharmacological Reviews · doi:10.1124/pr.112.007336 · Cited by 2,160
HIV Population Dynamics in Vivo: Implications for Genetic Variation, Pathogenesis, and Therapy
Coffin, J. M. (1995) · Science · doi:10.1126/science.7824947 · Cited by 1,981
Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor
Kohlstaedt, L. A., Wang, J., Friedman, J. M., Rice, P. A., & Steitz, T. A. (1992) · Science · doi:10.1126/science.1377403 · Cited by 1,914
Keele, B. F., Giorgi, E. E., Salazar-Gonzalez, J. F., Decker, J. M., Pham, K. T., Salazar, M. G., Sun, C., Grayson, T., Wang, S., Li, H., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802203105 · Cited by 1,912
The resurgence of covalent drugs
Singh, J., Petter, R. C., Baillie, T. A., & Whitty, A. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3410 · Cited by 1,873
RNA VIRUS MUTATIONS AND FITNESS FOR SURVIVAL
Domingo, E., & Holland, J. J. (1997) · Annual Review of Microbiology · doi:10.1146/annurev.micro.51.1.151 · Cited by 1,514
Huang, H., Chopra, R., Verdine, G. L., & Harrison, S. C. (1998) · Science · doi:10.1126/science.282.5394.1669 · Cited by 1,420
Agostini, M. L., Andres, E. L., Sims, A. C., Graham, R. L., Sheahan, T. P., Lu, X., Smith, E. C., Case, J. B., Feng, J. Y., Jordan, R., et al. (2018) · mBio · doi:10.1128/mbio.00221-18 · Cited by 1,416
Furman, P. A., Fyfe, J. A., St Clair, M. H., Weinhold, K., Rideout, J. L., Freeman, G. A., Lehrman, S. N., Bolognesi, D. P., Broder, S., & Mitsuya, H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.21.8333 · Cited by 1,347
Identification of four conserved motifs among the RNA-dependent polymerase encoding elements.
Poch, O., Sauvaget, I., Delarue, M., & Tordo, N. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08565.x · Cited by 1,202
Nucleotide sequence of the AIDS virus, LAV
Wain-Hobson, S., Sonigo, P., Danos, O., Cole, S., & Alizon, M. (1985) · Cell · doi:10.1016/0092-8674(85)90303-4 · Cited by 1,202
Multiple Mutations in HIV-1 Reverse Transcriptase Confer High-Level Resistance to Zidovudine (AZT)
Larder, B. A., & Kemp, S. D. (1989) · Science · doi:10.1126/science.2479983 · Cited by 1,163
Mansky, L. M., & Temin, H. M. (1995) · Journal of Virology · doi:10.1128/jvi.69.8.5087-5094.1995 · Cited by 1,154
Jacobo-Molina, A., Ding, J., Nanni, R. G., Clark, A. D., Lu, X., Tantillo, C., Williams, R. L., Kamer, G., Ferris, A. L., Clark, P., et al. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.13.6320 · Cited by 1,115
The accuracy of reverse transcriptase from HIV-1
Roberts, J. D., Bebenek, K., & Kunkel, T. A. (1988) · Science · doi:10.1126/science.2460925 · Cited by 997
Gordon, C. J., Tchesnokov, E. P., Woolner, E., Perry, J. K., Feng, J. Y., Porter, D. P., & Götte, M. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.013679 · Cited by 985
Characterization of ribosomal frameshifting in HIV-1 gag-pol expression
Jacks, T., Power, M. D., Masiarz, F. R., Luciw, P. A., Barr, P. J., & Varmus, H. E. (1988) · Nature · doi:10.1038/331280a0 · Cited by 966
Non-adherence to highly active antiretroviral therapy predicts progression to AIDS
Bangsberg, D. R., Perry, S., Charlebois, E. D., Clark, R. A., Roberston, M., Zolopa, A. R., & Moss, A. (2001) · AIDS · doi:10.1097/00002030-200106150-00015 · Cited by 960
Eastman, R. T., Roth, J. S., Brimacombe, K. R., Simeonov, A., Shen, M., Patnaik, S., & Hall, M. D. (2020) · ACS Central Science · doi:10.1021/acscentsci.0c00489 · Cited by 953
Resistance to ddI and Sensitivity to AZT Induced by a Mutation in HIV-1 Reverse Transcriptase
St. Clair, M. H., Martin, J. L., Tudor-Williams, G., Bach, M. C., Vavro, C. L., King, D. M., Kellam, P., Kemp, S. D., & Larder, B. A. (1991) · Science · doi:10.1126/science.1716788 · Cited by 679
HIV-1 assembly, release and maturation
Freed, E. O. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3490 · Cited by 654
An attempt to unify the structure of polymerases
Delarue, M., Poch, O., Tordo, N., Moras, D., & Argos, P. (1990) · "Protein Engineering, Design and Selection" · doi:10.1093/protein/3.6.461 · Cited by 637
Nowotny, M., Gaidamakov, S. A., Crouch, R. J., & Yang, W. (2005) · Cell · doi:10.1016/j.cell.2005.04.024 · Cited by 620
Sax, P. E., Wohl, D., Yin, M. T., Post, F., DeJesus, E., Saag, M., Pozniak, A., Thompson, M., Podzamczer, D., Molina, J. M., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60616-x · Cited by 601
Retroviral Recombination and Reverse Transcription
Hu, W.-S., & Temin, H. M. (1990) · Science · doi:10.1126/science.1700865 · Cited by 598
Jackson, P. A., Widen, J. C., Harki, D. A., & Brummond, K. M. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00788 · Cited by 588
Targeted Covalent Inhibitors for Drug Design
Baillie, T. A. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201601091 · Cited by 578
Crystal structure of the ribonuclease H domain of HIV-1 reverse transcriptase
Davies, J. F., Hostomska, Z., Hostomsky, Z., Jordan, S. R., & Matthews, D. A. (1991) · Science · doi:10.1126/science.1707186 · Cited by 570
Robertson, D. L., Sharp, P. M., McCutchan, F. E., & Hahn, B. H. (1995) · Nature · doi:10.1038/374124b0 · Cited by 562
Sarafianos, S. G., Marchand, B., Das, K., Himmel, D. M., Parniak, M. A., Hughes, S. H., & Arnold, E. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.10.071 · Cited by 535
Self-citationDas, K., Clark, Lewi, P. J., Heeres, J., de Jonge, M. R., Koymans, L. M. H., Vinkers, H. M., Daeyaert, F., Ludovici, D. W., Kukla, M. J., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030558s · Cited by 514
Redox-based reagents for chemoselective methionine bioconjugation
Lin, S., Yang, X., Jia, S., Weeks, A. M., Hornsby, M., Lee, P. S., Nichiporuk, R. V., Iavarone, A. T., Wells, J. A., Toste, F. D., et al. (2017) · Science · doi:10.1126/science.aal3316 · Cited by 513
Structure, Replication, and Recombination of Retrovirus Genomes: Some Unifying Hypotheses
Coffin, J. M. (1979) · Journal of General Virology · doi:10.1099/0022-1317-42-1-1 · Cited by 510
Hu, W.-S., & Hughes, S. H. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006882 · Cited by 505
High resolution structures of HIV-1 RT from four RT–inhibitor complexes
Ren, J., Esnouf, R., Garman, E., Somers, D., Ross, C., Kirby, I., Keeling, J., Darby, G., Jones, Y., Stuart, D., et al. (1995) · Nature Structural & Molecular Biology · doi:10.1038/nsb0495-293 · Cited by 502
Mechanism and fidelity of HIV reverse transcriptase.
Kati, W. M., Johnson, K. A., Jerva, L. F., & Anderson, K. S. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35706-5 · Cited by 492
Johnson, M. S., McClure, M. A., Feng, D. F., Gray, J., & Doolittle, R. F. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.20.7648 · Cited by 480
Christ, F., Voet, A., Marchand, A., Nicolet, S., Desimmie, B. A., Marchand, D., Bardiot, D., Van der Veken, N. J., Van Remoortel, B., Strelkov, S. V., et al. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.370 · Cited by 479
Hu, W. S., & Temin, H. M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1556 · Cited by 476
Time Trends in Primary HIV-1 Drug Resistance Among Recently Infected Persons
Grant, R. M. (2002) · JAMA · doi:10.1001/jama.288.2.181 · Cited by 459
Multiply infected spleen cells in HIV patients
Jung, A., Maier, R., Vartanian, J.-P., Bocharov, G., Jung, V., Fischer, U., Meese, E., Wain-Hobson, S., & Meyerhans, A. (2002) · Nature · doi:10.1038/418144a · Cited by 441
Dynamics of HIV-1 recombination in its natural target cells
Levy, D. N., Aldrovandi, G. M., Kutsch, O., & Shaw, G. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306764101 · Cited by 441
Hogg, R. S., Heath, K., Bangsberg, D., Yip, B., Press, N., O'Shaughnessy, M. V., & Montaner, J. S. G. (2002) · AIDS · doi:10.1097/00002030-200205030-00012 · Cited by 425
Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA:DNA
Sarafianos, S. G., Das, K., Tantillo, C., Clark, A. D., Ding, J., Whitcomb, J. M., Boyer, P. L., Hughes, S. H., & Arnold, E. (2001) · The EMBO Journal · doi:10.1093/emboj/20.6.1449 · Cited by 411
Self-citationde Béthune, M.-P. (2010) · Antiviral Research · doi:10.1016/j.antiviral.2009.09.008 · Cited by 401
Shirasaka, T., Kavlick, M. F., Ueno, T., Gao, W. Y., Kojima, E., Alcaide, M. L., Chokekijchai, S., Roy, B. M., Arnold, E., & Yarchoan, R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.6.2398 · Cited by 386
Daluge, S. M., Good, S. S., Faletto, M. B., Miller, W. H., St Clair, M. H., Boone, L. R., Tisdale, M., Parry, N. R., Reardon, J. E., Dornsife, R. E., et al. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.5.1082 · Cited by 384
High Rate of Recombination throughout the Human Immunodeficiency Virus Type 1 Genome
Jetzt, A. E., Yu, H., Klarmann, G. J., Ron, Y., Preston, B. D., & Dougherty, J. P. (2000) · Journal of Virology · doi:10.1128/jvi.74.3.1234-1240.2000 · Cited by 379
The structure of unliganded reverse transcriptase from the human immunodeficiency virus type 1.
Rodgers, D. W., Gamblin, S. J., Harris, B. A., Ray, S., Culp, J. S., Hellmig, B., Woolf, D. J., Debouck, C., & Harrison, S. C. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.4.1222 · Cited by 378
Usach, I., Melis, V., & Peris, J. (2013) · Journal of the International AIDS Society · doi:10.7448/ias.16.1.18567 · Cited by 373
Levin, J. G., Guo, J., Rouzina, & Musier‐Forsyth, K. (2005) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(05)80006-6 · Cited by 367
Boucher, C. A. B., O'Sullivan, E., Mulder, J. W., Ramautarsing, C., Kellam, P., Darby, G., Lange, J. M. A., Goudsmit, J., & Larder, B. A. (1992) · Journal of Infectious Diseases · doi:10.1093/infdis/165.1.105 · Cited by 352
Balzarini, J., Holy, A., Jindrich, J., Naesens, L., Snoeck, R., Schols, D., & De Clercq, E. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.2.332 · Cited by 350
Janssen, P. A. J., Lewi, P. J., Arnold, E., Daeyaert, F., de Jonge, M., Heeres, J., Koymans, L., Vinkers, M., Guillemont, J., Pasquier, E., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm040840e · Cited by 347
Arion, D., Kaushik, N., McCormick, S., Borkow, G., & Parniak, M. A. (1998) · Biochemistry · doi:10.1021/bi981200e · Cited by 345
Structure-based design of targeted covalent inhibitors
Lonsdale, R., & Ward, R. A. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00220c · Cited by 344
Das, K., Bauman, J. D., Clark, A. D., Frenkel, Y. V., Lewi, P. J., Shatkin, A. J., Hughes, S. H., & Arnold, E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711209105 · Cited by 343
Irreversible Protein Kinase Inhibitors: Balancing the Benefits and Risks
Barf, T., & Kaptein, A. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3003203 · Cited by 331
Ding, J., Das, K., Hsiou, Y., Sarafianos, S. G., Clark, A. D., Jacobo-Molina, A., Tantillo, C., Hughes, S. H., & Arnold, E. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2208 · Cited by 321
Self-citationCharneau, P., Alizon, M., & Clavel, F. (1992) · Journal of Virology · doi:10.1128/jvi.66.5.2814-2820.1992 · Cited by 312
Site-specific mutagenesis of AIDS virus reverse transcriptase
Larder, B. A., Purifoy, D. J. M., Powell, K. L., & Darby, G. (1987) · Nature · doi:10.1038/327716a0 · Cited by 312
Sarafianos, S. G., Das, K., Clark, A. D., Ding, J., Boyer, P. L., Hughes, S. H., & Arnold, E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.10027 · Cited by 309
Self-citationRuane, P. J., DeJesus, E., Berger, D., Markowitz, M., Bredeek, U. F., Callebaut, C., Zhong, L., Ramanathan, S., S. Rhee, M., Fordyce, M. W., et al. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3182965d45 · Cited by 302
Meyer, P. R., Matsuura, S. E., So, A. G., & Scott, W. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13471 · Cited by 298
Ding, J., Das, K., Moereels, H., Koymans, L., Andries, K., Janssen, P. A. J., Hughes, S. H., & Arnold, E. (1995) · Nature Structural & Molecular Biology · doi:10.1038/nsb0595-407 · Cited by 298
Azijn, H., Tirry, I., Vingerhoets, J., de Béthune, M.-P., Kraus, G., Boven, K., Jochmans, D., Van Craenenbroeck, E., Picchio, G., & Rimsky, L. T. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00986-09 · Cited by 293
Hsiou, Y., Ding, J., Das, K., Clark, Jr., Hughes, S., & Arnold, E. (1996) · Structure · doi:10.1016/s0969-2126(96)00091-3 · Cited by 289
Pathak, V. K., & Temin, H. M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.16.6019 · Cited by 280
Drug Resistance Mutations in HIV-1.
D’Aquila, R. T., Schapiro, J., Brun‐Vézinet, F., Clotet, B., Conway, B., Demeter, L. M., Grant, R. M., Johnson, V. A., Kuritzkes, D. R., Loveday, C., et al. (2002) · PubMed · Cited by 276
Das, K., Xiong, X., Yang, H., Westland, C. E., Gibbs, C. S., Sarafianos, S. G., & Arnold, E. (2001) · Journal of Virology · doi:10.1128/jvi.75.10.4771-4779.2001 · Cited by 274
Self-citationBacheler, L. T., Anton, E. D., Kudish, P., Baker, D., Bunville, J., Krakowski, K., Bolling, L., Aujay, M., Wang, X. V., Ellis, D., et al. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2475-2484.2000 · Cited by 268
Nature, Position, and Frequency of Mutations Made in a Single Cycle of HIV-1 Replication
Abram, M. E., Ferris, A. L., Shao, W., Alvord, W. G., & Hughes, S. H. (2010) · Journal of Virology · doi:10.1128/jvi.00915-10 · Cited by 267
Ren, J., Milton, J., Weaver, K. L., Short, S. A., Stuart, D. I., & Stammers, D. K. (2000) · Structure · doi:10.1016/s0969-2126(00)00513-x · Cited by 265
Selective Excision of AZTMP by Drug-Resistant Human Immunodeficiency Virus Reverse Transcriptase
Boyer, P. L., Sarafianos, S. G., Arnold, E., & Hughes, S. H. (2001) · Journal of Virology · doi:10.1128/jvi.75.10.4832-4842.2001 · Cited by 264
Self-citationOn the nature of virus quasispecies
EIGEN, M. (1996) · Trends in Microbiology · doi:10.1016/0966-842x(96)20011-3 · Cited by 262
Human Immunodeficiency Virus Type 1 Recombination: Rate, Fidelity, and Putative Hot Spots
Zhuang, J., Jetzt, A. E., Sun, G., Yu, H., Klarmann, G., Ron, Y., Preston, B. D., & Dougherty, J. P. (2002) · Journal of Virology · doi:10.1128/jvi.76.22.11273-11282.2002 · Cited by 262
Nowotny, M., & Yang, W. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601076 · Cited by 250
Lysine‐Targeting Covalent Inhibitors
Pettinger, J., Jones, K., & Cheeseman, M. D. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201707630 · Cited by 236
Perno, C. F., Yarchoan, R., Cooney, D. A., Hartman, N. R., Gartner, S., Popovic, M., Hao, Z., Gerrard, T. L., Wilson, Y. A., & Johns, D. G. (1988) · The Journal of experimental medicine · doi:10.1084/jem.168.3.1111 · Cited by 231
Covalent protein modification: the current landscape of residue-specific electrophiles
Shannon, D. A., & Weerapana, E. (2015) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2014.10.021 · Cited by 230
Primer tRNAs for reverse transcription
Mak, J., & Kleiman, L. (1997) · Journal of Virology · doi:10.1128/jvi.71.11.8087-8095.1997 · Cited by 225
Predicting the unpredictable: Transmission of drug-resistant HIV
Blower, S. M., Aschenbach, A. N., Gershengorn, H. B., & Kahn, J. O. (2001) · Nature Medicine · doi:10.1038/nm0901-1016 · Cited by 221
Whitcomb, J. M., Parkin, N. T., Chappey, C., Hellmann, N. S., & Petropoulos, C. J. (2003) · The Journal of Infectious Diseases · doi:10.1086/378281 · Cited by 216
The HIV-1 DNA flap stimulates HIV vector-mediated cell transduction in the brain
Zennou, V., Serguera, C., Sarkis, C., Colin, P., Perret, E., Mallet, J., & Charneau, P. (2001) · Nature Biotechnology · doi:10.1038/88115 · Cited by 214
Zhao, Q., Ma, L., Jiang, S., Lu, H., Liu, S., He, Y., Strick, N., Neamati, N., & Debnath, A. K. (2005) · Virology · doi:10.1016/j.virol.2005.06.008 · Cited by 212
Sax, P. E., Zolopa, A., Brar, I., Elion, R., Ortiz, R., Post, F., Wang, H., Callebaut, C., Martin, H., Fordyce, M. W., et al. (2014) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000225 · Cited by 207
kvasir: Release for Publication
Kevin Bonham, P. D. (2016) · PubMed · doi:10.5281/zenodo.53206 · Cited by 206
Isel, C., Lanchy, J. M., Le Grice, S. F., Ehresmann, C., Ehresmann, B., & Marquet, R. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00426.x · Cited by 203
Jurado, K. A., Wang, H., Slaughter, A., Feng, L., Kessl, J. J., Koh, Y., Wang, W., Ballandras-Colas, A., Patel, P. A., Fuchs, J. R., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300703110 · Cited by 203
Structures of HIV-1 reverse transcriptase with pre- and post-translocation AZTMP-terminated DNA
Sarafianos, S. G. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf637 · Cited by 199
Self-citationHawkins, T., Veikley, W., St. Claire, R. L., Guyer, B., Clark, N., & Kearney, B. P. (2005) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000167155.44980.e8 · Cited by 197
Mak, J., Jiang, M., Wainberg, M. A., Hammarskjöld, M. L., Rekosh, D., & Kleiman, L. (1994) · Journal of Virology · doi:10.1128/jvi.68.4.2065-2072.1994 · Cited by 194
The Journey of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) from Lab to Clinic
Namasivayam, V., Vanangamudi, M., Kramer, V. G., Kurup, S., Zhan, P., Liu, X., Kongsted, J., & Byrareddy, S. N. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00843 · Cited by 191
Das, K., Martinez, S. E., Bauman, J. D., & Arnold, E. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2223 · Cited by 190
Gao, G., Orlova, M., Georgiadis, M. M., Hendrickson, W. A., & Goff, S. P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.407 · Cited by 188
Das, K., Ding, J., Hsiou, Y., Clark, A. D., Moereels, H., Koymans, L., Andries, K., Pauwels, R., Janssen, P. A. J., Boyer, P. L., et al. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0698 · Cited by 188
Vingerhoets, J., Tambuyzer, L., Azijn, H., Hoogstoel, A., Nijs, S., Peeters, M., de Béthune, M.-P., De Smedt, G., Woodfall, B., & Picchio, G. (2010) · AIDS · doi:10.1097/qad.0b013e32833677ac · Cited by 185
HIV reverse transcriptase structure-function relationships
Jacobo-Molina, A., & Arnold, E. (1991) · Biochemistry · doi:10.1021/bi00240a001 · Cited by 183
Ren, J., Nichols, C., Bird, L., Chamberlain, P., Weaver, K., Short, S., Stuart, D. I., & Stammers, D. K. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4988 · Cited by 183
HIV virology and pathogenetic mechanisms of infection: a brief overview
Fanales-Belasio, E., Raimondo, M., Suligoi, B., & Buttò, S. (2010) · Annali dellIstituto Superiore di Sanità · doi:10.1590/s0021-25712010000100002 · Cited by 183
White, K. L., Margot, N. A., Wrin, T., Petropoulos, C. J., Miller, M. D., & Naeger, L. K. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.11.3437-3446.2002 · Cited by 180
Ren, J., Esnouf, R., Hopkins, A., Ross, C., Jones, Y., Stammers, D., & Stuart, D. (1995) · Structure · doi:10.1016/s0969-2126(01)00226-x · Cited by 178
Rimsky, L., Vingerhoets, J., Van Eygen, V., Eron, J., Clotet, B., Hoogstoel, A., Boven, K., & Picchio, G. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31823df4da · Cited by 173
HIV-1 reverse transcriptase and antiviral drug resistance. Part 1
Das, K., & Arnold, E. (2013) · Current Opinion in Virology · doi:10.1016/j.coviro.2013.03.012 · Cited by 168
HIV and the spectrum of human disease
Lucas, S., & Nelson, A. M. (2015) · The Journal of Pathology · doi:10.1002/path.4449 · Cited by 166
Gunawardana, M., Remedios-Chan, M., Miller, C. S., Fanter, R., Yang, F., Marzinke, M. A., Hendrix, C. W., Beliveau, M., Moss, J. A., Smith, T. J., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00656-15 · Cited by 166
Small-Molecule CD4 Mimics Interact with a Highly Conserved Pocket on HIV-1 gp120
Madani, N., Schön, A., Princiotto, A. M., LaLonde, J. M., Courter, J. R., Soeta, T., Ng, D., Wang, L., Brower, E. T., Xiang, S.-H., et al. (2008) · Structure · doi:10.1016/j.str.2008.09.005 · Cited by 164
Wassner, C., Bradley, N., & Lee, Y. (2020) · Journal of the International Association of Providers of AIDS Care (JIAPAC) · doi:10.1177/2325958220919231 · Cited by 163
Structures of HIV-1 RT–DNA complexes before and after incorporation of the anti-AIDS drug tenofovir
Tuske, S., Sarafianos, S. G., Clark, A. D., Ding, J., Naeger, L. K., White, K. L., Miller, M. D., Gibbs, C. S., Boyer, P. L., Clark, P., et al. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb760 · Cited by 161
Self-citationHarrigan, P. R., Stone, C., Griffin, P., Nájera, I., Bloor, S., Kemp, S., Tisdale, M., Larder, B., & the CNA2001 Investigative Group (2000) · The Journal of Infectious Diseases · doi:10.1086/315317 · Cited by 159
Shaw-Reid, C. A., Munshi, V., Graham, P., Wolfe, A. L., Witmer, M. V., Danzeisen, R. C., Olsen, D. B., Carroll, S. S., Embrey, M. W., Wai, J. S. M., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200621200 · Cited by 159
Deval, J., White, K. L., Miller, M. D., Parkin, N. T., Courcambeck, J., Halfon, P., Selmi, B., Boretto, J., & Canard, B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308806200 · Cited by 159
Shafer, R. W., & Vuitton, D. A. (1999) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(99)80063-8 · Cited by 156
Development of non-nucleoside reverse transcriptase inhibitors (NNRTIs): our past twenty years
Zhuang, C., Pannecouque, C. C., Clercq, E. D., & Chen, F. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.11.010 · Cited by 155
Persistence of primary drug resistance among recently HIV-1 infected adults
Barbour, J. D., Hecht, F. M., Wrin, T., Liegler, T. J., Ramstead, C. A., Busch, M. P., Segal, M. R., Petropoulos, C. J., & Grant, R. M. (2004) · AIDS · doi:10.1097/01.aids.0000131391.91468.ff · Cited by 153
Koh, Y., Matsumi, S., Das, D., Amano, M., Davis, D. A., Li, J., Leschenko, S., Baldridge, A., Shioda, T., Yarchoan, R., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703938200 · Cited by 151
RNase H activity: structure, specificity, and function in reverse transcription
Schultz, S. J., & Champoux, J. J. (2008) · Virus Research · doi:10.1016/j.virusres.2007.12.007 · Cited by 150
Vernekar, S. K. V., Liu, Z., Nagy, E., Miller, L., Kirby, K. A., Wilson, D. J., Kankanala, J., Sarafianos, S. G., Parniak, M. A., & Wang, Z. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501132s · Cited by 150
Self-citationSarafianos, S. G., Das, K., Hughes, S. H., & Arnold, E. (2004) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2004.10.013 · Cited by 147
Self-citationReardon, J. E. (1992) · Biochemistry · doi:10.1021/bi00133a013 · Cited by 147
Winters, M. A., Shafer, R. W., Jellinger, R. A., Mamtora, G., Gingeras, T., & Merigan, T. C. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.4.757 · Cited by 147
HIV-1 reverse transcriptase: crystallization and analysis of domain structure by limited proteolysis
Lowe, D. M., Aitken, A., Bradley, C., Darby, G. K., Larder, B. A., Powell, K. L., Purifoy, D. J. M., Tisdale, M., & Stammers, D. K. (1988) · Biochemistry · doi:10.1021/bi00425a002 · Cited by 146
Melikian, G., Rhee, S., Varghese, V., Porter, D., White, K., Taylor, J., Towner, W. J., Troia-Cancio, P. V., Burack, J. H., DeJesus, E., et al. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt316 · Cited by 145
Michailidis, E., Marchand, B., Kodama, E. N., Singh, K., Matsuoka, M., Kirby, K. A., Ryan, E. M., Sawani, A. M., Nagy, E., Ashida, N., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.036616 · Cited by 143
Self-citationIn Vitro Characterization of MK-1439, a Novel HIV-1 Nonnucleoside Reverse Transcriptase Inhibitor
Lai, M., Feng, M., Falgueyret, J., Tawa, P., Witmer, M. V., DiStefano, D. J., Li, Y., Burch, J. D., Sachs, N. A., Lu, M., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02403-13 · Cited by 143
Opravil, M., Hirschel, B. J., Lazzarin, A., Furrer, H., Chave, J., Yerly, S., Bisset, L. R., Fischer, M., Vernazza, P., Bernasconi, E., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/340312 · Cited by 134
Kawamoto, A., Kodama, E. N., Sarafianos, S. G., Sakagami, Y., Kohgo, S., Kitano, K., Ashida, N., Iwai, Y., Hayakawa, H., Nakata, H., et al. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.04.007 · Cited by 130
Self-citationMarkowitz, M. H., Zolopa, A. R., Squires, K., Ruane, P. J., Coakley, D. F., Kearney, B. P., Zhong, L., Wulfsohn, M. S., Miller, M. D., & Lee, W. A. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt532 · Cited by 130
Nakashima, H., Matsui, T., Harada, S., Kobayashi, N., Matsuda, A., Ueda, T., & Yamamoto, N. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.30.6.933 · Cited by 127
Extended-Duration MK-8591-Eluting Implant as a Candidate for HIV Treatment and Prevention
Barrett, S. E., Teller, R. S., Forster, S. P., Li, L., Mackey, M. A., Skomski, D., Yang, Z., Fillgrove, K. L., Doto, G. J., Wood, S. L., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01058-18 · Cited by 127
Rous sarcoma virus genome is terminally redundant: the 3' sequence.
Schwartz, D. E., Zamecnik, P. C., & Weith, H. L. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.3.994 · Cited by 124
Structural basis of HIV-1 resistance to AZT by excision
Tu, X., Das, K., Han, Q., Bauman, J. D., Clark, A. D., Hou, X., Frenkel, Y. V., Gaffney, B. L., Jones, R. A., Boyer, P. L., et al. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1908 · Cited by 124
Self-citationHsiou, Y., Das, K., Ding, J., Clark, A. D., Kleim, J., Rösner, M., Winkler, I., Riess, G., Hughes, S. H., & Arnold, E. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2171 · Cited by 124
Gao, H., Boyer, P. L., Sarafianos, S. G., Arnold, E., & Hughes, S. H. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.3823 · Cited by 123
Self-citationYahi, N., Tamalet, C., Tourrès, C., Tivoli, N., Ariasi, F., Volot, F., Gastaut, J., Gallais, H., Moreau, J., & Fantini, J. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.12.4099-4106.1999 · Cited by 123
Michailidis, E., Huber, A. D., Ryan, E. M., Ong, Y. T., Leslie, M. D., Matzek, K. B., Singh, K., Marchand, B., Hagedorn, A. N., Kirby, K. A., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.562694 · Cited by 122
Self-citationNalam, M. N. L., Ali, A., Altman, M. D., Reddy, G. S., Chellappan, S., Kairys, V., Özen, A., Cao, H., Gilson, M. K., Tidor, B., et al. (2010) · Journal of Virology · doi:10.1128/jvi.02531-09 · Cited by 120
Harrigan, P. R., Kinghorn, I., Bloor, S., Kemp, S. D., Nájera, I., Kohli, A., & Larder, B. A. (1996) · Journal of Virology · doi:10.1128/jvi.70.9.5930-5934.1996 · Cited by 119
Potent Nonnucleoside Reverse Transcriptase Inhibitors Target HIV-1 Gag-Pol
Figueiredo, A., Moore, K. L., Mak, J., Sluis‐Cremer, N., de Béthune, M., & Tachedjian, G. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020119 · Cited by 118
Feng, M., Wang, D., Grobler, J. A., Hazuda, D. J., Miller, M. D., & Lai, M. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04201-14 · Cited by 117
Wegner, S. A., Brodine, S. K., Mascola, J. R., Tasker, S. A., Shaffer, R. A., Starkey, M. J., Barile, A. J., Martin, G. J., Aronson, N., Emmons, W. W., et al. (2000) · AIDS · doi:10.1097/00002030-200005260-00013 · Cited by 115
Hooker, D. J., Tachedjian, G., Solomon, A. E., Gurusinghe, A. D., Land, S., Birch, C. J., Anderson, J. L., Roy, B. M., Arnold, E., & Deacon, N. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.11.8010-8018.1996 · Cited by 114
Potential anti-AIDS drugs. 2',3'-Dideoxycytidine analogs
Kim, C. H., Márquez, V. E., Broder, S. E., Mitsuya, H., & Driscoll, J. S. (1987) · Journal of Medicinal Chemistry · doi:10.1021/jm00388a020 · Cited by 113
Patel, D., Bauman, J. D., & Arnold, E. (2014) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2014.08.004 · Cited by 112
Babusis, D. M., Phan, T. K., Lee, W. A., Watkins, W. J., & Ray, A. S. (2012) · Molecular Pharmaceutics · doi:10.1021/mp3002045 · Cited by 111
Tachedjian, G., Orlova, M., Sarafianos, S. G., Arnold, E., & Goff, S. P. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121055998 · Cited by 110
Self-citationCurrent and emerging non-nucleoside reverse transcriptase inhibitors (NNRTIs) for HIV-1 treatment
Wang, Y., Clercq, E. D., & Li, G. (2019) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2019.1673367 · Cited by 110
Côté, B., Burch, J. D., Asante‐Appiah, E., Bayly, C., Bedard, L. L., Blouin, M., Campeau, L., Cauchon, E., Chan, M., Chefson, A., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.12.070 · Cited by 108
Salie, Z. L., Kirby, K. A., Michailidis, E., Marchand, B., Singh, K., Rohan, L. C., Kodama, E. N., Mitsuya, H., Parniak, M. A., & Sarafianos, S. G. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1605223113 · Cited by 107
Self-citationA supramolecular assembly mediates lentiviral DNA integration
Ballandras-Colas, A., Maskell, D. P., Serrao, E., Locke, J., Swuec, P., Jónsson, S. R., Kotecha, A., Cook, N. J., Pye, V. E., Taylor, I. A., et al. (2017) · Science · doi:10.1126/science.aah7002 · Cited by 107
Structural basis for strand-transfer inhibitor binding to HIV intasomes
Passos, D. O., Li, M., Jóźwik, I. K., Zhao, X. Z., Santos-Martins, D., Yang, R., Smith, S. J., Jeon, Y., Forli, S., Hughes, S. H., et al. (2020) · Science · doi:10.1126/science.aay8015 · Cited by 106
Más, A., Parera, M., Briones, C., Soriano, V., Martı́nez, M. Á., Domingo, E., & Menéndez‐Arias, L. (2000) · The EMBO Journal · doi:10.1093/emboj/19.21.5752 · Cited by 106
Duwe, S. C., Brunn, M., Altmann, D., Hamouda, O., Schmidt, B., Walter, H., Pauli, G., & cherer, C. K. ⁄. (2001) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200103010-00010 · Cited by 105
Rhee, S., Liu, T. F., Ravela, J., Gonzales, M. J., & Shafer, R. W. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.8.3122-3126.2004 · Cited by 104
Margot, N., Lu, B., Cheng, A., Miller, M., & the Study 903 Team (2006) · HIV Medicine · doi:10.1111/j.1468-1293.2006.00404.x · Cited by 103
Walsh, J. C., Pozniak, A., Nelson, M. R., Mandalia, S., & Gazzard, B. (2002) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200207010-00003 · Cited by 102
Schürmann, D., Rudd, D. J., Zhang, S., Lepeleire, I. D., Robberechts, M., Friedman, E. J., Keicher, C., Hüser, A., Hofmann, J., Grobler, J. A., et al. (2020) · The Lancet HIV · doi:10.1016/s2352-3018(19)30372-8 · Cited by 101
HIV-1 reverse transcriptase and antiviral drug resistance. Part 2
Das, K., & Arnold, E. (2013) · Current Opinion in Virology · doi:10.1016/j.coviro.2013.03.014 · Cited by 100
Snapshot of the equilibrium dynamics of a drug bound to HIV-1 reverse transcriptase
Kuroda, D. G., Bauman, J. D., Challa, J. R., Patel, D., Troxler, T., Das, K., Arnold, E., & Hochstrasser, R. M. (2013) · Nature Chemistry · doi:10.1038/nchem.1559 · Cited by 97
Feng, M., Sachs, N. A., Xu, M., Grobler, J. A., Blair, W. S., Hazuda, D. J., Miller, M. D., & Lai, M. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02650-15 · Cited by 97
4′-Ethynyl-2-fluoro-2′-deoxyadenosine, MK-8591
Markowitz, M. H., & Sarafianos, S. G. (2018) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000467 · Cited by 97
Self-citationBauman, J. D., Patel, D., Dharia, C., Fromer, M. W., Ahmed, S., Frenkel, Y. V., Vijayan, R., Eck, J. T., Ho, W. C., Das, K., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301271j · Cited by 95
Ruiz, F. X., & Arnold, E. (2020) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2019.11.011 · Cited by 95
Boyer, P. L., Sarafianos, S. G., Arnold, E., & Hughes, S. H. (2002) · Journal of Virology · doi:10.1128/jvi.76.18.9143-9151.2002 · Cited by 94
Self-citationTambuyzer, L., Azijn, H., Rimsky, L. T., Vingerhoets, J., Lecocq, P., Kraus, G., Picchio, G., & de Béthune, M. (2009) · Antiviral Therapy · doi:10.1177/135965350901400114 · Cited by 93
Whitcomb, J. M., Kumar, R. V., & Hughes, S. H. (1990) · Journal of Virology · doi:10.1128/jvi.64.10.4903-4906.1990 · Cited by 92
Jochmans, D., Deval, J., Kesteleyn, B., Marck, H. G. V., Bettens, E., Baere, I. D., Dehertogh, P., Ivens, T., Ginderen, M. V., Schoubroeck, B. V., et al. (2006) · Journal of Virology · doi:10.1128/jvi.00889-06 · Cited by 92
Krakower, D., & Mayer, K. H. (2015) · Drugs · doi:10.1007/s40265-015-0355-4 · Cited by 91
Das, K., Bandwar, R. P., White, K., Feng, J. Y., Sarafianos, S. G., Tuske, S. J., Tu, X., Clark, A. D., Boyer, P. L., Hou, X., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.022525 · Cited by 91
Self-citationThe Nature of Human Immunodeficiency Virus Type 1 Strand Transfers
Yu, H., Jetzt, A. E., Ron, Y., Preston, B. D., & Dougherty, J. P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.43.28384 · Cited by 91
Determining the Relative Efficacy of Highly Active Antiretroviral Therapy
Louie, M. J., Hogan, C., Mascio, M. D., Hurley, A., Simon, V. R., Rooney, J. F., Ruíz, N., Brun, S., Sun, E., Perelson, A. S., et al. (2003) · The Journal of Infectious Diseases · doi:10.1086/368164 · Cited by 89
Martín‐Hernández, A. M., Domingo, E., & Menéndez‐Arias, L. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00816.x · Cited by 88
HIV-1 ribonuclease H: structure, catalytic mechanism and inhibitors
Beilhartz, G. L., & Götte, M. (2010) · Viruses · doi:10.3390/v2040900 · Cited by 88
Kulkarni, R., Babaoglu, K., Lansdon, E. B., Rimsky, L. T., Eygen, V. V., Picchio, G., Svarovskaia, E. S., Miller, M. D., & White, K. (2011) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31823aca74 · Cited by 87
Hayashi, H., Takamune, N., Nirasawa, T., Aoki, M., Morishita, Y., Das, D., Koh, Y., Ghosh, A. K., Misumi, S., & Mitsuya, H. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400027111 · Cited by 86
Julias, J. G., & Pathak, V. K. (1998) · Journal of Virology · doi:10.1128/jvi.72.10.7941-7949.1998 · Cited by 86
Imamichi, T., Berg, S. C., Imamichi, H., Lopez, J. C., Metcalf, J. A., Falloon, J., & Lane, H. C. (2000) · Journal of Virology · doi:10.1128/jvi.74.23.10958-10964.2000 · Cited by 83
Powell, M. D., Ghosh, M. P., Jacques, P. S., Howard, K. J., Grice, S. F. J. L., & Levin, J. G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.20.13262 · Cited by 82
Tenofovir Resistance and Resensitization
Wolf, K., Walter, H., Beerenwinkel, N., Keulen, W., Kaiser, R., Hoffmann, D. E., Lengauer, T., Selbig, J., Vandamme, A., Korn, K., et al. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.11.3478-3484.2003 · Cited by 82
Ren, J., Nichols, C. E., Chamberlain, P. P., Weaver, K. L., Short, S. A., & STAMMERS, D. K. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.12.055 · Cited by 81
Mechanism of resistance of human immunodeficiency virus type 1 to 2',3'-dideoxyinosine.
Martin, J. L., Wilson, J. E., Haynes, R. L., & Furman, P. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.13.6135 · Cited by 79
Jacques, P. S., Wöhrl, B. M., Ottmann, M., Darlix, J., & Grice, S. F. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47218-3 · Cited by 78
Stoll, E., Billeter, M., Palmenberg, A. C., & Weissmann, C. (1977) · Cell · doi:10.1016/0092-8674(77)90185-4 · Cited by 78
Recent Progress in the Design of Small Molecule Inhibitors of HIV RNase H
Klumpp, K., & Mirzadegan, T. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206776873653 · Cited by 76
White, K., Chen, J., Margot, N., Wrin, T., Petropoulos, C. J., Naeger, L. K., Swaminathan, S., & Miller, M. D. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.3.992-1003.2004 · Cited by 76
Site-directed Mutagenesis of Arginine 72 of HIV-1 Reverse Transcriptase
Sarafianos, S. G., Pandey, V. N., Kaushik, N., & Modak, M. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.34.19729 · Cited by 74
Self-citationSmith, J. S., & Roth, M. J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42147-3 · Cited by 73
Stoddart, C. A., Galkina, S. A., Joshi, P., Kosikova, G., Moreno, M. E., Rivera, J. M., Sloan, B. A., Reeve, A. B., Sarafianos, S. G., Murphey‐Corb, M., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05036-14 · Cited by 73
Self-citationPullen, K. A., Ishimoto, L. K., & Champoux, J. J. (1992) · Journal of Virology · doi:10.1128/jvi.66.1.367-373.1992 · Cited by 72
Ren, J., Nichols, C. E., Chamberlain, P. P., Weaver, K. L., Short, S. A., Chan, J. H., Kleim, J., & STAMMERS, D. K. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061117m · Cited by 72
Abram, M. E., Ferris, A. L., Das, K., Quiñones, O. A., Shao, W., Tuske, S. J., Alvord, W. G., Arnold, E., & Hughes, S. H. (2014) · Journal of Virology · doi:10.1128/jvi.00302-14 · Cited by 71
Corona, A., Leva, F. S. D., Thierry, S., Pescatori, L., Crucitti, G. C., Subra, F., Delelis, O., Esposito, F., Rigogliuso, G., Costi, R., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03605-14 · Cited by 71
Xu, H., Colby-Germinario, S. P., Asahchop, E. L., Oliveira, M., McCallum, M., Schader, S. M., Han, Y.-S., Quan, Y., Sarafianos, S. G., & Wainberg, M. A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00348-13 · Cited by 69
Self-citationMarchand, B., Tchesnokov, E., & Götte, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607710200 · Cited by 69
Kavlick, M. F., Wyvill, K. M., Yarchoan, R., & Mitsuya, H. (1998) · The Journal of Infectious Diseases · doi:10.1086/515324 · Cited by 69
Research works printed but not linked: 8
- Vogt V., 1997, Retroviruses
- Telesnitsky A., 1997, Retroviruses
- Volberding P., 2002, AIDS Read., 12, 349
- D’Aquila R. T., 2003, Top HIV Med., 11, 92
- Kirby K. A., 2011, Cell. Mol. Biol., 57, 40
- Grobler, J. A.; Fillgrove, K.; Hazuda, D.; Huang, Q.; Lai, M. T.; Matthews, R. P.; Rudd, D. J.; Vargo, R. MK-8591 potency and PK provide high inhibitory quotients at low doses QD and QW. In Conference on Retroviruses and Opportunistic Infections (CROI), Seattle, WA , 2019; 481, http://www.croiconference.org/sessions/mk-8591-potency-and-pk-provide-high-inhibitory-quotients-low-doses-qd-and-qw (accessed 2020-07-13).
- Bekker, L-G.; Li, S. S.; Tolly, B.; Marzinke, M. A.; Mgodi, N.; Justman, J. E.; Swaminathan, S.; Adeyeye, A.; Farrior, J. H.; Sista, N. Hptn 076:Tmc278 ls safe, tolarable, and acceptable for HIV preexposure prophylaxis. In Proceedings of the Conference on Retroviruses and Opportunistic Infections, Seattle, WA , 2017.
- 2011, Janssen Products
Cited by
Recent Advances in Pyrimidine-Based Drugs
Nammalwar, B., & Bunce, R. A. (2024) · Pharmaceuticals · doi:10.3390/ph17010104 · Cited by 192
Approved HIV reverse transcriptase inhibitors in the past decade
Li, G., Wang, Y., & Clercq, E. D. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.11.009 · Cited by 144
Xue, Y., Liu, C., Andrews, G., Wang, J., & Ge, Y. (2022) · Nano Convergence · doi:10.1186/s40580-022-00307-9 · Cited by 115
HIV drug resistance in the era of contemporary antiretroviral therapy: A clinical perspective
Carr, A., Mackie, N., Paredes, R., & Ruxrungtham, K. (2023) · Antiviral Therapy · doi:10.1177/13596535231201162 · Cited by 89
“1,17,18 The high replication rate, error-prone reverse transcription and high recombination rate of HIV give rise to a genetically diverse, heterogeneous virus population that is distributed as a quasispecies.”
BackgroundInfluentialWang, Z., Cherukupalli, S., Xie, M., Wang, W., Jiang, X., Jia, R., Pannecouque, C. C., Clercq, E. D., Kang, D., Zhan, P., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01758 · Cited by 78
Metadata
- Authors
- Cilento, M. E., Kirby, K. A., & Sarafianos, S. G.
- Affiliations
- Emory University (US)
- Corresponding author
- Sarafianos, Stefan G.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2021-01-28
- Volume
- 121
- Issue
- 6
- Pages
- 3271-3296
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- PMC
- PMC8149104
- OpenAlex
- W3125954347
- Cited by
- 106
- References
- 305
- Citations by year
- 2026: 15 · 2025: 22 · 2024: 27 · 2023: 17 · 2022: 18 · 2021: 7
- FWCI
- 2.28
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Chemical Reviews (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01 AI121315, R37 AI076119, U54 AI150472)
- National Institute of General Medical Sciences (R01 GM118012, T32 GM008367)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- HIV reverse transcriptase, drug resistance, reverse transcriptase inhibitors, resistance mutations, HIV drug development, antiretroviral therapy
- MeSH terms
- Humans, Models, Molecular, Mutation, Protein Binding, Protein Conformation, Structure-Activity Relationship, Virus Replication, Drug Design, Signal Transduction, HIV-1, HIV Infections, Reverse Transcriptase Inhibitors, Anti-HIV Agents, Drug Resistance, Viral, HIV Reverse Transcriptase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.